Göttingen scientists use BESSY II to decode basic mechanism underlying biochemical reactions

Structure of the sugar molecule bound by the enzyme transketolase immediately prior to its being split

Structure of the sugar molecule bound by the enzyme transketolase immediately prior to its being split

Enzymes are life’s molecular catalysts and figure prominently in cellular metabolism. It has been speculated that in the course of a biochemical reaction enzymes physically bend their substrates to split them. Now for the first time ever, scientists at the Göttingen Center for Molecular Biosciences (GZMB) have successfully used BESSY II's MX beamline to unequivocally confirm this hypothesis. The results from this study have been published in the renowned scientific journal Nature Chemistry.

The Göttingen team around Prof. Dr. Kai Tittmann and Prof. Dr. Ralf Ficner started out by growing high order protein crystals of the human enzyme transketolase, which plays a central role in human metabolism during sugar processing. Natural sugar substrates were added to the protein crystals. Analysis of the enzyme’s crystalline structure was subsequently performed at electron storage ring BESSY II's MX beamline and in French Grenoble. The scientists were able to determine the structure of the sugar molecule bound by the enzyme immediately prior to its being split in half at an ultrahigh spatial resolution of 0.1 nanometers. “The snapshot we got of an enzyme at work, which really is unprecedented in terms of resolution, unequivocally reveals how the sugar substrate is being bent by the enzyme, similar to a vise clamping a work piece,” Prof. Tittmann explains.

In many cases, enzymes are drug targets. Which is why these new insights are important for the development of customized, highly specific active substances like those used in cancer therapy. “Even the human transketolase used in this study plays a key role in cancer cell metabolism,” says Prof. Tittmann.

Source: Göttingen University

  • Copy link

You might also be interested in

  • Key technology for a future without fossil fuels
    Interview
    21.08.2025
    Key technology for a future without fossil fuels
    In June and July 2025, catalyst researcher Nico Fischer spent some time at HZB. It was his sabbatical, he was relieved of his duties as Director of the Catalysis Institute in Cape Town for several months and was able to focus on research only. His institute is collaborating with HZB on two projects that aim to develop environmentally friendly alternatives using innovative catalyst technologies. The questions were asked by Antonia Rötger, HZB.
  • 5000th patient treated with protons for eye tumours
    News
    19.08.2025
    5000th patient treated with protons for eye tumours
    For more than 25 years, Charité – Universitätsmedizin Berlin and the Helmholtz-Zentrum Berlin (HZB) have been jointly offering proton radiation therapy for eye tumours. The HZB operates a proton accelerator in Berlin-Wannsee for this purpose, while Charité provides medical care for the patients. The 5000th patient was treated at the beginning of August.
  • Scrolls from Buddhist shrine virtually unrolled at BESSY II
    Science Highlight
    23.07.2025
    Scrolls from Buddhist shrine virtually unrolled at BESSY II
    The Mongolian collection of the Ethnological Museum of the National Museums in Berlin contains a unique Gungervaa shrine. Among the objects found inside were three tiny scrolls, wrapped in silk. Using 3D X-ray tomography, a team at HZB was able to create a digital copy of one of the scrolls. With a mathematical method the scroll could be virtually unrolled to reveal the scripture on the strip. This method is also used in battery research.